(Q44791811)

English

Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

object named as

Paul M Stewart

0 references

author name string

John Ayuk

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Susan E Stewart

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Michael C Sheppard

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

European Sandostatin LAR Group

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

375-381

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Epidemiology of acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Octreotide as primary therapy for acromegaly.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.01992.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2004.01992.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44791811&oldid=2042077088"